⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OCUL News
Ocular Therapeutix, Inc.
Form 8-K
sec.gov
OCUL
Form 8-K
sec.gov
OCUL
Ocular Therapeutix™ Reports Third Quarter 2026 Financial Results and Business Highlights
globenewswire.com
OCUL
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
OCUL
Ocular Therapeutix™ to Report Third Quarter 2026 Financial Results on November 9, 2026
globenewswire.com
OCUL
Ocular Therapeutix™ to Participate in November Investor and Scientific Conferences
globenewswire.com
OCUL
Form 8-K
sec.gov
OCUL
Controlled Release Drug Delivery Market Size, Share, Trends, and Global Forecast, 2026-2036 | Market to Reach USD 172.3 Billion as Long-Acting Therapies and Biologic Delivery Drive 8.7% CAGR
globenewswire.com
JNJ
PFE
NVS
TEVA
ALKS
OCUL
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
OCUL
Ocular Therapeutix™ to Participate in October Scientific and Investor Conferences
globenewswire.com
OCUL